ObjectiveHemoglobin A1c (HbA(1c)) has been widely used as a clinically important assessment tool for outcome analyses related to glycemic control. However, because of special conditions in dialysis patients, including the uremic milieu, there is no HbA(1c) blood glucose (BG) equation specific for patients on dialysis. In this study, we sought to develop HbA(1c)-BG equation models for hemodialysis patients.Research design and methodsWe examined associations between HbA(1c) and random serum BG over time in a contemporary cohort of diabetic patients with hemodialysis treated in DaVita dialysis clinics. We identified 11,986 patients (63 ± 12 years old and 49% male) with 69,764 paired measurements of HbA(1c) and BG over the course of 5 years (20...
Diabetes mellitus (DM) constitutes a major end-stage renal disease (ESRD) health problem. Glycemic c...
OBJECTIVE-Lowering hemoglobin A(1c) to <7% reduces the risk of microvascular complications of diabet...
Little is known about the predictive value of glycosylated hemoglobin (HbA1C) variability in patient...
ObjectiveHemoglobin A1c (HbA(1c)) has been widely used as a clinically important assessment tool for...
OBJECTIVEdHemoglobin A1c (HbA1c) has been widely used as a clinically important assess-ment tool for...
HbA1c has been widely used as a clinically important assessment tool for outcome analyses related to...
HbA1c has been widely used as a clinically important assessment tool for outcome analyses related to...
BackgroundAlthough hemoglobin A1c (HbA1c) has been widely used as a clinical assessment tool for out...
The definition of a good glycemic control in patients with diabetes mellitus on hemodialysis is far ...
Glycated albumin is thought to more accurately reflect glycemic control in diabetic hemodialysis pat...
Background and Objectives: Glycated hemoglobin (HbA1c) dosage is considered the gold standard in gly...
ObjectiveThe optimal target for glycemic control has not been established in diabetic dialysis patie...
BACKGROUND: Improved glycemic control reduces complications in patients with diabetes mellitus (DM)....
PURPOSE: The optimal target for glycemic control has not been established for diabetic maintenance h...
Almost half the patients on peritoneal dialysis are diabetic and glycemic control is essential to im...
Diabetes mellitus (DM) constitutes a major end-stage renal disease (ESRD) health problem. Glycemic c...
OBJECTIVE-Lowering hemoglobin A(1c) to <7% reduces the risk of microvascular complications of diabet...
Little is known about the predictive value of glycosylated hemoglobin (HbA1C) variability in patient...
ObjectiveHemoglobin A1c (HbA(1c)) has been widely used as a clinically important assessment tool for...
OBJECTIVEdHemoglobin A1c (HbA1c) has been widely used as a clinically important assess-ment tool for...
HbA1c has been widely used as a clinically important assessment tool for outcome analyses related to...
HbA1c has been widely used as a clinically important assessment tool for outcome analyses related to...
BackgroundAlthough hemoglobin A1c (HbA1c) has been widely used as a clinical assessment tool for out...
The definition of a good glycemic control in patients with diabetes mellitus on hemodialysis is far ...
Glycated albumin is thought to more accurately reflect glycemic control in diabetic hemodialysis pat...
Background and Objectives: Glycated hemoglobin (HbA1c) dosage is considered the gold standard in gly...
ObjectiveThe optimal target for glycemic control has not been established in diabetic dialysis patie...
BACKGROUND: Improved glycemic control reduces complications in patients with diabetes mellitus (DM)....
PURPOSE: The optimal target for glycemic control has not been established for diabetic maintenance h...
Almost half the patients on peritoneal dialysis are diabetic and glycemic control is essential to im...
Diabetes mellitus (DM) constitutes a major end-stage renal disease (ESRD) health problem. Glycemic c...
OBJECTIVE-Lowering hemoglobin A(1c) to <7% reduces the risk of microvascular complications of diabet...
Little is known about the predictive value of glycosylated hemoglobin (HbA1C) variability in patient...